Berrak, Ozge <br/><br/>
mTOR is a fine tuning molecule in CDK inhibitors-induced distinct cell death mechanisms via PI3K/AKT/mTOR signaling axis in prostate cancer cells.  [electronic resource] 

 -  Apoptosis : an international journal on programmed cell death  10 2016 
 - 1158-78 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1573-675X 
<br/><br/><label>Standard No.: </label>10.1007/s10495-016-1275-9  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Apoptosis--drug effects<br/>Autophagy--drug effects<br/>Cell Cycle--drug effects<br/>Cell Line, Tumor<br/>Cell Proliferation--drug effects<br/>Humans<br/>Male<br/>Prostatic Neoplasms--drug therapy<br/>Protein Kinase Inhibitors--pharmacology<br/>Proto-Oncogene Proteins c-akt--genetics<br/>Purines--pharmacology<br/>Receptors, Androgen--genetics<br/>Roscovitine<br/>Signal Transduction--drug effects<br/>TOR Serine-Threonine Kinases--genetics